Tonzonium
Drug profile
Also known as: thonzide, thonzonium, thonzonium bromide, tonzonium bromide
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Tonzonium is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 1962. DrugCentral lists 2 molecular targets, including Dyrk1a and IDE. Recorded indications include Mastoidectomy Cavity Infections and Otitis externa.
- Approval status: ofp (first approved 1962 by the FDA).
- Molecular targets: Dyrk1a and IDE (2 listed in DrugCentral).
- Indications: Mastoidectomy Cavity Infections and Otitis externa.
- Molecular formula: C32H55N4O; molecular weight 511.82 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Mastoidectomy Cavity Infections
- Otitis externa
Off-label uses (1)
- Chronic purulent otitis media
Contraindications (7)
- Bullous myringitis
- Fungal ear infection
- Herpes simplex
- Herpes zoster auricularis
- Perforation of tympanic membrane
- Tuberculosis of ear
- Viral ear infection
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Dyrk1a | unknown | AC50 5.03 |
| Insulin-degrading enzyme | IDE | unknown | EC50 4.27 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1962-05-17 | FDA | — | PAR STERILE PRODUCTS |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Tonzonium is on its molecule page.
| Molecular formula | C32H55N4O |
|---|---|
| Molecular weight | 511.82 g/mol |
| CAS number | 553-08-2 |
| InChIKey | IOYZYMQFUSNATM-UHFFFAOYSA-N |
| PubChem CID | 5456 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Tonzonium used for?
DrugCentral lists the following indications for Tonzonium: Mastoidectomy Cavity Infections and Otitis externa.
How does Tonzonium work?
Its molecular targets in DrugCentral include Dyrk1a and IDE.
When was Tonzonium first approved?
Tonzonium was first approved by the FDA in 1962.
What is the chemical formula of Tonzonium?
Tonzonium has the molecular formula C32H55N4O and a molecular weight of 511.82 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4605 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200883 — compound record and bioactivity
- PubChem CID 5456 — chemical identifiers
- DrugBank DB09552 — drug record
- FDA UNII JI2B19CR0R — substance identity
- DailyMed: FDA labels for Tonzonium — current prescribing information (label search)
- UniProt P14735 (IDE) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.